Stay updated on Surufatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib in Advanced Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new revision indication: v3.4.2, and removed the government funding notice along with the earlier revision indication (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding lapse notice at the top of the page and updated the page revision to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedMinor UI text updates were made, including the glossary toggle label, capitalization of QC criteria wording, and the site revision indicator. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed, representing a minor administrative update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a consolidated Locations section listing California, Colorado, Florida, New York, Tennessee, Texas, and Virginia. Replaced the previous per-state location subsections with the consolidated Locations section and updated Revision: v3.3.3.SummaryDifference0.7%

Stay in the know with updates to Surufatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.